Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Fulcrum Therapeutics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Layoffs: 1 exit or restructuring plan reported on Form 8-K, Item 2.05 (latest filed 2026-06-04, about 57 jobs).
- Leadership changes: the latest reported is Alan Musso (Form 8-K filed 2026-08-10). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Montanova Capital, LLC (filed 2026-08-14).
Who is behind it
Fulcrum Therapeutics, Inc.: incorporated in Delaware; business address in Cambridge, Massachusetts; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Montanova Capital, LLC | 5.5% |
| Schedule 13G, 2026-08-14 | Nantahala Capital Management, LLC | 8.22% |
| Schedule 13G/A, 2026-08-14 | Tcg Crossover Gp Ii, LLC | 0% |
| Schedule 13G/A, 2026-08-14 | Ra Capital Management, L.P. | 0% |
| Schedule 13G, 2026-08-03 | Bank Of America Corp /De/ | 6.7% |
| Schedule 13G/A, 2026-07-28 | Blackrock, Inc. | 7.2% |
| Schedule 13G, 2026-07-17 | Blackrock Portfolio Management LLC | 6% |
| Schedule 13G/A, 2026-07-15 | Tang Capital Management, LLC | 10.4% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-10 | Alan Musso | appointed | 2026-08-07 | |
| Form 8-K, 2026-06-11 | Greg Tourangeau | Vice President, Finance | departed | |
| Form 8-K, 2026-04-27 | Josh Lehrer | Director | appointed | |
| Form 8-K, 2026-04-27 | Josh Lehrer | appointed | ||
| Form 8-K, 2026-04-27 | Alan Musso | departed |
Money raised
No fundraising or offering filing from Fulcrum Therapeutics, Inc. is on file with us.
Red flags found
1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2026-06-04).
Related pages
LayoffsLeadership changes5%+ holders
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/fulcrum-therapeuticsLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-08-14 · Form 8-K, 2026-08-10 · Form 8-K, 2026-06-11 · Form 8-K, 2026-04-27
Who owns Fulcrum Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/fulcrum-therapeutics